Next Generation News and Research

RSS

Focusing on oncogenic driver mutations and resistance mechanisms in the treatment of NSCLC

Lung cancer is the leading cause of cancer-related death worldwide. Improved understanding of driver mutations of non-small cell lung cancer (NSCLC) has led to more biomarker-directed treatment for patients with advanced stages.

26 Mar 2024

New genetic system analyzes the underlying mechanisms of CRISPR-based DNA repair outcomes

Since its breakthrough development more than a decade ago, CRISPR has revolutionized DNA editing across a broad range of fields.

26 Mar 2024

Study identifies key priorities for building mental health-friendly cities for young people

As cities around the world continue to draw young people for work, education, and social opportunities, a new study identifies characteristics that would support young urban dwellers' mental health.

26 Mar 2024

Children with multiple sclerosis have better outcomes if treated early and with high-efficacy therapies

A ground-breaking study – the largest of its kind globally – has found children with multiple sclerosis (MS) have better outcomes if treated early and with the same high-efficacy therapies as adults.

25 Mar 2024

Nucleus Genomics ushers in a new era of personalized medicine to the public

Nucleus Genomics, the next-generation genetic testing and analysis company, today announced the launch of its DNA analysis product to bring the benefits of personalized medicine to everyone.

25 Mar 2024

Mount Sinai launches first study on high-resolution brain-computer interface

A multidisciplinary team of neurosurgeons and neuroscientists from the Icahn School of Medicine at Mount Sinai are the first in New York to study a new brain-computer interface that's engineered to map a large area of the brain's surface, in real time, at resolutions hundreds of times more detailed than typical arrays used in neurosurgical procedures.

22 Mar 2024

Scientists uncover four proteins that govern the identity of anaplastic large cell lymphoma

A collaboration between scientists from St. Jude Children's Research Hospital and Dana-Farber Cancer Institute uncovered four proteins that govern the identity of anaplastic large cell lymphoma (ALCL), an aggressive form of cancer.

22 Mar 2024

Using whole genome sequencing to identify non-culturable Legionella

Legionnaires' disease (LD), a rare and severe type of pneumonia, is a respiratory infection caused by species of Legionella bacteria.

21 Mar 2024

Nuclera joins Tech Nation’s Future Fifty program

Nuclera recognized as one of UK’s most exciting growth stage companies.

From Nuclera 20 Mar 2024

Developing mRNA lipid nanoparticles for treating oral squamous cell carcinoma

A study aiming to develop a Lipid nanoparticles (LNP) platform for treating oral squamous cell carcinoma (OSCC) utilizing p53 mRNA was presented at the 102nd General Session of the IADR, which was held in conjunction with the 53rd Annual Meeting of the American Association for Dental, Oral, and Craniofacial Research and the 48th Annual Meeting of the Canadian Association for Dental Research, on March 13-16, 2024, in New Orleans, LA, USA.

19 Mar 2024

Ownership-based text messages boost COVID booster uptake

New research published in Nature Human Behavior suggests that text nudges encouraging people to get the COVID-19 vaccine, which had proven effective in prior real-world field tests, are also effective at prompting people to get a booster.

18 Mar 2024

Study examines parents' support behavior in relation to school grades of children

The Max Planck Institute for Demographic Research has researched parents' support behavior in relation to school grades.

15 Mar 2024

Milestone in diabetes treatment: Transgenic cow produces human insulin in milk

An unassuming brown bovine from the south of Brazil has made history as the first transgenic cow capable of producing human insulin in her milk.

14 Mar 2024

Novel CAR-T therapy shows promising results in glioblastoma patients

A collaborative project to bring the promise of cell therapy to patients with a deadly form of brain cancer has shown dramatic results among the first patients to receive the novel treatment.

13 Mar 2024

World Vaccine Congress draws leaders from government, science and industry

Sessions cover topics from cancer vaccines to logistics and the next.

From World Vaccine Congress Washington 13 Mar 2024

New custom-designed proteins can efficiently reach intramembrane targets

Hitting targets embedded within the cell membrane has long been difficult for drug developers due to the membrane's challenging biochemical properties. Now, Scripps Research chemists have demonstrated new custom-designed proteins that can efficiently reach these "intramembrane" targets.

13 Mar 2024

Mount Sinai's new department will connect medical care with public health

The Icahn School of Medicine at Mount Sinai, fulfilling its commitment to connecting medical care with public health, today established a new Department of Public Health under the visionary leadership of Rosalind J. Wright, MD, MPH, the Horace W. Goldsmith Professor in Children's Health Research at Icahn Mount Sinai.

12 Mar 2024

Maternal obesity linked to liver cancer risk in offspring

Obesity, which could reach 50% of the population in certain developed countries by 2030, is a major public health concern.

12 Mar 2024

The brain may use a single shared blueprint to guide early development, study suggests

In a new study published in Proceedings of the National Academy of Sciences (PNAS), researchers from the University of Minnesota Medical School investigated brain development to understand how different areas of the brain become specialized in handling information such as vision, sound, touch and planning.

11 Mar 2024

Scripps Research tests wearable devices as relief for long COVID symptoms

Scientists at the Scripps Research Digital Trials Center have partnered with the health technology company CareEvolution to launch a remote study that will investigate whether wrist-worn devices, such as activity trackers and smartwatches, can help people with long COVID manage and reduce the severity of their symptoms.

11 Mar 2024

Next Generation News and Research

Focusing on oncogenic driver mutations and resistance mechanisms in the treatment of NSCLC

New genetic system analyzes the underlying mechanisms of CRISPR-based DNA repair outcomes

Study identifies key priorities for building mental health-friendly cities for young people

Children with multiple sclerosis have better outcomes if treated early and with high-efficacy therapies

Nucleus Genomics ushers in a new era of personalized medicine to the public

Mount Sinai launches first study on high-resolution brain-computer interface

Scientists uncover four proteins that govern the identity of anaplastic large cell lymphoma

Using whole genome sequencing to identify non-culturable Legionella

Nuclera joins Tech Nation’s Future Fifty program

Developing mRNA lipid nanoparticles for treating oral squamous cell carcinoma

Ownership-based text messages boost COVID booster uptake

Study examines parents' support behavior in relation to school grades of children

Milestone in diabetes treatment: Transgenic cow produces human insulin in milk

Novel CAR-T therapy shows promising results in glioblastoma patients

World Vaccine Congress draws leaders from government, science and industry

New custom-designed proteins can efficiently reach intramembrane targets

Mount Sinai's new department will connect medical care with public health

Maternal obesity linked to liver cancer risk in offspring

The brain may use a single shared blueprint to guide early development, study suggests

Scripps Research tests wearable devices as relief for long COVID symptoms

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News